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Abstract
The tremendous success of S. aureus as a human pathogen has been explained primarily by its array of virulence factors that
enable the organism to evade host immunity. Perhaps equally important, but less well understood, is the importance of the
intensity of the host response in determining the extent of pathology induced by S. aureus infection, particularly in the
pathogenesis of pneumonia. We compared the pathogenesis of infection caused by two phylogenetically and
epidemiologically distinct strains of S. aureus whose behavior in humans has been well characterized. Induction of the
type I IFN cascade by strain 502A, due to a NOD2-IRF5 pathway, was the major factor in causing severe pneumonia and
death in a murine model of pneumonia and was associated with autolysis and release of peptidogylcan. In contrast to
USA300, 502A was readily eliminated from epithelial surfaces in vitro. Nonetheless, 502A caused significantly increased
tissue damage due to the organisms that were able to invade systemically and trigger type I IFN responses, and this was
ameliorated in Ifnar-/- mice. The success of USA300 to cause invasive infection appears to depend upon its resistance to
eradication from epithelial surfaces, but not production of specific toxins. Our studies illustrate the important and highly
variable role of type I IFN signaling within a species and suggest that targeted immunomodulation of specific innate
immune signaling cascades may be useful to prevent the excessive morbidity associated with S. aureus pneumonia.
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Introduction
Staphylococcus aureus is an important pathogen causing skin and
soft tissue infections as well as pneumonia and superinfection post
influenza [1]. The development of antibiotic resistance, in
particular methicillin resistant S. aureus (MRSA) and the highly
transmissible clone USA300 are of significant concern [2,3]. While
USA300 strains can colonize humans asymptomatically, they can
lead to invasive infections, causing substantial morbidity and
mortality [4,5]. It is now practice to de-colonize patients in
hospital settings to prevent infection [6]. The success of S. aureus is
greatly attributed to its expression of multiple virulence factors
however, the inflammatory response is a major component of the
host pathology produced by infection. Multiple cell types in the
lung participate in recognition and acute response to infection
such as epithelial cells, macrophages, neutrophils and dendritic
cells [7]. These cells in turn activate numerous signaling cascades
in response to S. aureus PAMPs in the airway and these overlapping
responses can contribute to pathology [8].
One host pathway activated upon S. aureus infection is the type I
IFN pathway [9,10]. Although initially identified for its role in
viral infections type I IFN signaling is activated by bacteria via
several different intracellular and cytosolic receptors [11,12]. S.
aureus USA300 activates this pathway via TLR9 recognition of
DNA [10]. Activation of the pathway leads to production of IFN-
b that binds to its cognate receptor interferon alpha/beta receptor,
IFNAR, leading to downstream gene products [13]. To determine
the impact of specific human innate immune responses on the
pathogenesis of invasive S. aureus infection, we compared two
divergent strains of S. aureus; the MRSA strain USA300 that is
currently epidemic in the USA and the penicillin susceptible 502A,
once considered as non-pathogenic [14].
Strain 502A was used extensively in the 1960’s in bacterial
interference studies, whereby its colonization of newborns
protected them against the virulent circulating strain [14–16].
Thousands of infants were effectively colonized via nares and
umbilicus with 502A and it was later shown adults could also be
colonized and protected against invasive strains [17]. 502A was
able to persist for months, rarely causing infection. However, some
studies did point to localized infections and one case of sepsis was
reported [18,19]. Even though 502A displayed great benefit, to
our knowledge no studies were undertaken to understand why it
was not invasive or the mechanism(s) associated with its only
occasional cases of disease.
We were interested if differential sensing by the host contributed
to the disparate pathogenicity of S. aureus USA300 and 502A, why
is USA300 associated with local or systemic infection in colonized
hosts while 502A for the most part remains superficial and is not
virulent. The distinctive responses of USA300 and 502A could be
due to individual virulence factors; alternatively the nature of the
host response could explain their mechanisms of pathogenesis. We
show that a distinguishing characteristic of USA300 is its ability to
invade into to cross the mucosal barrier and its ability to cause
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pathology beyond this barrier is actually less than the non-invasive
502A strain. We show herein that the non-invasive S. aureus strain
502A leads to differential type I IFN signaling. This type I IFN
response is activated by uptake of live bacteria that signal via
NOD2 and IRF5, in contrast to USA300. In a model of acute
pneumonia 502A unexpectedly causes significantly more pathol-
ogy and disease that is the result of host type I IFN signaling.
Results
502A is less invasive than USA300
While both USA300 and 502A are capable of colonizing
humans, USA300, unlike 502A, is highly invasive [5,14,20]. We
directly compared their relative ability to penetrate mucosal
barriers. Comparison of 502A to USA300 in gentamicin
protection assays of several primary and immortalized skin cells
lines showed 502A to have reduced invasiveness. Invasion of 502A
was 60% less than USA300 in human keratinocyte HaCat cells
(P,0.01), 83% less in primary human keratinocytes (P,0.01) and
73% less in human nasal epithelial cells (P,0.001) (Figure 1A).
The reduced invasiveness of 502A was not due to host-derived
killing as uptake of 502A was equivalent at early time points
compared to USA300 (Figure 1B) but by 2 h 57% less HaCat cells
had 502A inside of them (Figure 1B). Invasiveness of both strains
was further tested by incubation with polarized airway epithelial
cells and assessing their ability to migrate across the epithelial
barrier. While USA300 transmigrated on average at levels of
1.86104 cfu to the basolateral compartment, 502A was over 27-
fold less at 6.66102 cfu, on average (Figure 1C).
We hypothesized that the reduced invasiveness of 502A might
be due to increased susceptibility to cell wall targeted killing. We
found that 502A bacterial numbers remaining in the apical
compartment from polarized 16HBE transmigration experiments
were reduced by over 63-fold (P,0.05) compared to USA300
(Figure 1C). Similarly, incubation of 502A with spent media from
the HaCat human keratinocyte line led to a 27-fold reduction
(P,0.01) in 502A numbers compared to USA300 (Figure 1D).
These data indicate that 502A is less invasive and is unable to cross
the epithelial barrier, entirely consistent with the clinical data
showing remarkably little invasion despite high inocula given to
neonates.
The genome of 502A contains similar virulence potential
to USA300
To gain insight into the disparate invasive properties of USA300
and 502A we sequenced the genome of 502A. Phylogenetic
analysis using concatenated genome data shows 502A to be
genetically distinct from USA300, more closely related to the
MRSA strains JH1, JH9, Mu3, Mu50 and N315 (Figure 2)
[21,22]. Analysis of virulence factor composition between the two
strains revealed a high level of conservation at both the gene and
nucleotide level (Figure 2). All the major virulence factors
including a-toxin, leukocidins, adhesion factors, protein A, iron
acquisition genes, phenol soluble modulins and regulatory factors
were present. We did not observe differences in protein level for a-
toxin while there was a decrease in protein A (Figure S1). At the
nucleotide level there was a high level of identity, the exception
was fibronectin binding protein A and B with 85% nucleotide
identity between USA300 and 502A. One difference was the
enterotoxin complement of genes, USA300 encodes sek and seq
while 502A encoded several including seg, sei, sem and sen (Figure 2).
Consistent with 502A not being a MRSA or USA300 strain, it did
not encode for the Panton-Valentine leukocidin or the arginine
catabolic mobile element (ACME) [2] that has been shown to aid
survival in the acidic environment found on the skin [23,24].
Thus, analysis of the genome of 502A indicated it possesses many
of the virulence factors to cause disease.
502A displays enhanced virulence in a murine
pneumonia model
Although 502A was used extensively in infants to protect against
infection from other more virulent S. aureus strains prevalent at the
time [14,15], there were several cases of local infection and
septicemia as a result of 502A inoculation [18,19]. We therefore
investigated the ability of 502A to cause infection when the
mucosal barrier is bypassed, in a model of acute murine
pneumonia.
At an inoculum that leads to zero mortality in mice with
USA300 (76107 cfu), mortality with 502A was 100% (P,0.01)
(Figure 3A). In a model of acute pneumonia (2–56107 cfu) 502A
displayed increased virulence as compared to USA300 with an
average of 1.26105 cfu in BALF compared to 3.26102 USA300.
This increased bacterial burden was also evident in lung tissue,
502A counts were 5-fold higher than USA300 (Figure 3B).
Indicative of the high bacterial counts, 502A infected mice had
higher (978 vs 547 mg/ml, P,0.001) protein content in their
BALF, an indicator of lung injury (Figure 3C). There were
increased numbers of cells recruited to the airway of 502A infected
mice, significantly more dendritic cells (82.5% more, P,0.05) and
natural killer cells (346%, P,0.01) were recovered from the
airways of 502A infected mice (Figure 3D) and significantly greater
concentrations of the inflammatory cytokines CXCL1/KC (1043
vs 75 mg/ml, 1290% increased, P,0.001) and IL-6 (986 vs
244 mg/ml, 304% increase, P,0.001) compared to USA300
infected mice (Figure 3E). Levels of IL-1b and TNF were elevated
in 502A infected mice, but were not significantly different between
the two strains. These results indicate that when the mucosal
barrier is bypassed, 502A is able to cause increased inflammation,
cytokine expression and lung injury as compared to USA300.
We hypothesized the in vivo results could be explained by a
differential host response. We stimulated mouse lung epithelial
cells (Figure 4A), mouse bone marrow derived macrophages
Author Summary
The virulence of the S. aureus, and especially that
associated with the epidemic MRSA USA300 strains, has
been primarily explained by its expression of a specific set
of virulence factors. We postulated that that intensity of
the host innate immune response activated by specific
staphylococcal strains is also critical in determining the
severity of infection. By comparing two divergent S. aureus
strains, USA300, associated with invasive disease, and
502A, primarily associated with surface colonization, we
found that virulence was directly associated with the
ability of a strain to stimulate the type I interferon
pathway. The morbidity and mortality associated with
USA300 could be attributed to its resistance to killing at
mucosal surfaces; once past the epithelial barrier it caused
less pathology than 502A. In contrast, although 502A was
more readily killed by epithelial antimicrobial factors, once
into the lung, it caused significantly more pathology in a
mouse model of acute pneumonia. These observations
suggest that modulating the host response to infection
may be useful in preventing some of the disease
associated with S. aureus pneumonia.
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(BMM) (Figure 4B) and dendritic cells (BMDC) (Figure 4C) with
USA300 and 502A and examined gene expression. Consistent
across all three cell types was a substantial increase in type I IFN
induction, as indicated by increased Ifnb levels. We observed 105-
fold, 65-fold and 7.7-fold increases in Ifnb induction by 502A
compared to USA300 in each of the cells types respectively. In the
Figure 1. S. aureus 502A is less invasive than USA300. A) Invasiveness of USA300 and 502A was assessed by gentamicin protection assays in
HaCat, human keratinocyte (HKc) and human nasal epithelial cells (HNE). Data is presented as a percentage of USA300 bacterial counts (n = 6). B)
Uptake of fluorescently labeled S. aureus into HaCat cells. n = 3. C) Transmigration assay of USA300 and 502A. 56107 cfu of each strain was applied to
the apical side of polarized 16HBE airway epithelial cells for 24 h before bacteria were enumerated in the basolateral and apical compartments
(n = 16). D) Spent 24 h HaCat culture supernatants were incubated with 26107 cfu/ml of USA300 or 502A for 24 h before bacteria were enumerated.
Data are from at least two independent experiments. ***P,0.001, **P,0.01 and *P,0.05 compared to USA300.
doi:10.1371/journal.ppat.1003951.g001
Figure 2. Whole genome phylogeny and heat map of gene content. The phylogenetic tree was constructed using whole genome alignment
of gene coding regions for the strains pictured using the maximum parsimony (MP) optimality criterion (32,097 parsimony informative characters).
Branch lengths are proportional to the number of nucleotide changes inferred for each branch. * denotes branches with 100% bootstrap support.
The MP tree length was 74,526 steps (rescaled consistency index= 0.658). The staphylococcal genome MSH1132 was used as an outgroup. The heat
map shows percent nucleotide identity over the entire sequence length based on BLAST comparison to each representative gene from the S. aureus
TCH1516 genome as a query sequence. The area boxed in red shows comparisons using S. aureus 502A genes as queries. A cutoff of .84%
nucleotide identity was used to determine presence of each gene. # denotes BLAST alignments of less than 95% of the sequence gene length.
USA300 strains (FPR3757 and TCH1516) and 502A are highlighted in black boxes.
doi:10.1371/journal.ppat.1003951.g002
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immune cells, this differential gene induction was limited to Ifnb
and not classical NF-kB-derived products such as Cxcl1/KC, Il6 or
Tnf (Figure 4) indicating that the elevated Ifnb response was not
due to increased bacterial load (Figure S2). We confirmed our
mouse cell observations in the human monocytic cell line THP-1
and again observed 502A induces significantly more Ifnb (65-fold
compared to 2.8-fold) than USA300 (Figure 4D). The increased
signaling did not necessarily correlate with bacterial growth
(Figure S2). Concomitant with the increased signaling we observed
increased in LDH release (Figure S2). These data suggest that the
increased virulence in mice may be the result of increased host
signaling, namely type I IFN in response to 502A.
502A activates a NOD2-IRF5 pathway
USA300 has been shown to activate type I IFN signaling
through TLR9 [10]. As type I IFN signaling is activated by
bacterial PAMPs that gain access to intracellular receptors, we first
documented the ability of 502A to be internalized, then
determined the components involved in the pathway. Activation
of type I IFN signaling by 502A required live organisms, as heat
killed 502A induced 90% less Ifnb than live bacteria (Figure 5A), in
contrast to USA300 that had no difference in signaling when heat
inactivated [10]. The levels of Ifnb induction by heat killed 502A
were similar to those observed with live USA300 [10].
As dendritic cells are phagocytic, we investigated the role of
uptake of 502A as a requirement for type I IFN activation. In the
presence of cytochalasin D, an inhibitor of actin polymerization,
induction of Ifnb was reduced by 97% (P,0.001) (Figure 5B).
Inhibition of dynamin-mediated endocytosis was demonstrated by
treating cells with dynasore, which inhibits the GTPase activity of
dynamin [25] that led to a 91% decrease (P,0.001) in Ifnb
induction in response to 502A (Figure 5B). In contrast to USA300
[10], Ifnb induction by 502A was not inhibited by chloroquine,
which indicated a lack of endosomal TLR involvement. Induction
was inhibited by bafilomycin that inhibits the vacuolar H+ATPase,
V-ATPase [26] (93% reduction, P,0.001) (Figure 5B). Cellular
uptake was confirmed by the visualization of 502A as well as
USA300 inside BMDC. S. aureus were labeled with a pH indicator
dye, such that only those cells inside acidic compartments
fluoresced red (Figure 5C) however, we did not observe any
major differences in intracellular location between the strains. By
2 hours we did observe reduced numbers of 502A inside BMDC
compared to USA300 (Figure 5C).
Based on our observations that uptake and processing were
required for activation of type I IFN by 502A we examined several
intracellular and cytosolic adaptor and receptor proteins associ-
ated with induction of type I IFN. In addition to an involvement of
MyD88, we observed that NOD2 was also required (Figure 5D).
As opposed to USA300, TLR9 was not involved in sensing of
502A [10]. Cells lacking NOD2 induced 83% less Ifnb (P,0.001)
in response to 502A. We further confirmed the involvement of
NOD2 by inhibiting its downstream kinase RIP2 with the
Figure 3. 502A displays increased virulence in a murine model of acute pneumonia. A) S. aureus USA300 and 502A were infected
intranasally (108 cfu) for 20 h in C57Bl/6J mice and mortality assessed (n = 5). WT C57Bl/6J mice were infected with 107 cfu of each strain for 20 h. B)
BALF and lung homogenate were assessed for bacterial numbers. C) Total protein content in BALF (n = 8). D) Cells in BALF were stained with
fluorescent antibodies and analyzed by flow cytometry. E) Cytokines were measure by ELISA from BALF. Data are from at least two independent
experiments. Each point represents a mouse. Lines display median values. ***P,0.001, **P,0.01 and *P,0.05, compared to WT infected controls.
doi:10.1371/journal.ppat.1003951.g003
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inhibitor gefitinib [27] (85% reduction, P,0.01) (Figure 5E). As
gefitinib can also inhibit EGFR we showed that AG1478, a specific
EGFR inhibitor did not influence Ifnb induction to the same
degree as gefitinib (Figure 5E).
The involvement of NOD2 in type I IFN activation is not fully
characterized [28–30]. We screened BMDC from mice lacking
several different interferon regulatory factors (IRF) for Ifnb
induction in response to 502A and identified IRF5 as being the
major IRF associated with induction by 502A. BMDC lacking
IRF5 had a 67% decrease in Ifnb induction. In addition we also
observed that mice lacking both IRF3 and IRF7 had 35% less
(P,0.05) Ifnb induction (Figure 5F). To determine the effects of
NOD2-mediated signaling we compared levels of gene transcript
between WT and Nod2-/- BMDC. Nod2-/- BMDC did not express
reduced levels of Cxcl1/KC or Tnf, but did express significantly
reduced levels of Il6 (82% reduction, P,0.001) and Cxcl10 (60%
reduction, P,0.01), gene products known to be influenced by type
I IFN (Figure 5G). Consistent with our RNA data, significantly
reduced levels of IFN-b were detected in MyD88-/-, Nod2-/- and
Irf5-/- BMDC. Levels of 502A induced IFN-b were reduced by
30% (P,0.001) and 35% (P,0.001) in Nod2-/- and Irf5-/- BMDC
respectively compared to WT cells. IFN-b in Nod2-/- and Irf5-/-
cells in response to 502A and USA300 were equivalent
(Figure 5H). Thus the increased type I IFN response by 502A
appears to be the result of signaling via NOD2 and IRF5 and
suggests that specific staphylococcal strains can activate different
mechanisms of sensing and activation of type I IFN signaling.
Increased 502A autolysis correlates with IFN-b induction
NOD2 recognizes muramyl dipeptide of peptidoglycan, sam-
pling peptidoglycan from whole as well as lysed bacteria in the
cytosol [31,32]. Accordingly we postulated that 502A might be
more autolytic thus providing increased PAMPs to activate the
host response. We first examined the growth rates of 502A and
USA300 and consistently observed a faster exponential growth
phase by 502A (Figure 6A). 502A also displays significantly greater
autolysis compared to USA300 in a triton X-100 autolysis assay
(Figure 6B). Increased amounts of the major staphylococcal
autolysin, Atl, was present in the secreted fraction of cultures as
identified by mass spectrometry (Figure 6C; controls Figure S3).
Increased autolysis was further suggested by the susceptibility of
502A to lysostaphin (Figure 6D), an endopeptidase that specifically
targets peptidoglycan in the cell wall of staphylococci [33] as well
as increased susceptibility to cell wall directed antibiotics (data not
shown).
The contribution of other PAMPs to induction of Ifnb was
evaluated. Purified DNA, RNA and lysates of USA300 and 502A,
or 502A lysates treated with DNase, RNase and protease elicited
no significant differences in Ifnb induction and also between the
two strains (Figure 6E–G). We also examined purified peptido-
glycan from both strains in two forms, insoluble and soluble
(digested with mutanolysin and lysostaphin overnight). Insoluble
peptidoglycan gave equivalent low levels of induction regardless of
the presence of transfection reagent. Soluble peptidoglycan, upon
transfection, induced a 5000-fold increased in Ifnb (Figure 6H),
much more than other agonists however, no differences were
observed between strains. As autolysis should release cell contents
we quantified peptidoglycan levels from cultures. Exponential
phase cultures of 502A had significantly (16%, P,0.05) higher
levels of peptidoglycan compared to USA300 (Figure 6I). After
interaction with host cells, we saw an even greater difference with
a 100% increase (P,0.01) in peptidoglycan in 502A treated cells
compared to USA300 treated (Figure 6I). These observations
suggest that the enhanced autolysis of 502A releases highly
Figure 4. S. aureus 502A has enhanced induction of type I IFN signaling. S. aureus USA300 and 502A were incubated with A) mouse lung
epithelial cells, B) murine bone marrow derived macrophages or C) murine bone marrow derived dendritic cells for 2 h and levels of Ifnb, Cxcl1(KC), Il6
and Tnf determined using qRT-PCR. D) Ifnb levels in THP-1 cells after 2 h incubation of S. aureus USA300 or 502A. Data are representative of two
independent experiments. N = 3. ***P,0.001, **P,0.01 and *P,0.05 compared to USA300.
doi:10.1371/journal.ppat.1003951.g004
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stimulatory peptidoglycan providing greater NOD2 stimulation
than USA300 to activate the type I IFN pathway.
Type I IFN signaling contributes to the pathogenicity of
502A
To determine the contribution of type I IFN signaling to the host
response by 502A we compared WT and Ifnar-/- mice lacking the
type I IFN receptor, in our model of murine acute pneumonia. At a
higher inoculum of bacteria we observed a significant decrease in
mouse mortality. Only 50% of Ifnar-/- mice succumbed to infection
compared to 92% of WT mice (P,0.05) (Figure 7A). When mice
were intranasally infected with a lower inoculum we observed a 5.2-
fold reduction in bacterial burden in the BALF (P,0.05) and 61-fold
less bacteria in lung tissue (P,0.01) (Figure 7B). This decrease in
bacterial burden in the airway was also evident in diminished lung
damage. Total protein content in BALF, an indicator of injury was
reduced by 40% (P,0.05) in 502A infected Ifnar-/- compared to WT
infected animals (Figure 7C). We also observed reductions in
immune cell recruitment to the airway in Ifnar-/- infected mice.
Neutrophils were reduced by 74% in Ifnar-/- mice (WT-3.66104/ml,
Ifnar-/--9.46103/ml; P,0.05) and dendritic cells were reduced by
52% (WT-120 cells/ml, Ifnar-/--58 cells/ml; P,0.05) (Figure 7D).
These reductions were a likely reflection of the reduced bacterial
burden. As a further indicator of the host response to the infection we
quantitated cytokine levels in the BALF. We observed significant
decreases in both CXCL1/KC and IL-1b levels (Figure 7E).
CXCL1 levels were reduced by 56% in Ifnar-/- infected mice
compared to WT infected animals (1701 vs 747 pg/ml; P,0.05)
while IL-1b levels were reduced by 60% (53 pg/ml vs 21 pg/ml;
P,0.01) levels not significantly different from uninfected mice
(Figure 7E). The cumulative effect of the reduced bacterial burden
and immune response was illustrated in H&E stained lung sections.
These showed that in response to 502A, WT mice exhibited
increased consolidation, cellular infiltrate and loss of alveolar
architecture as compared to the Ifnar-/- mice (Figure 8). Thus, the
induction of type I IFN signaling by 502A contributes significantly to
the virulence of this organism in a model of pneumonia.
Discussion
S. aureus infections are a tremendous cause of human morbidity
and mortality. Despite the intense interest in their epidemiology and
mechanisms of pathogenesis, very basic questions regarding their
Figure 5. Induction of type I IFN by 502A requires endocytosis, Nod2 and IRF5. BMDC were stimulated by A) live or heat killed 502A, or B)
live 502A in the presence of various inhibitors for 2 h before Ifnb induction was analyzed by qRT-PCR (n = 3). CytoD-cytochalasin D, Dyn-dynasore, Baf-
bafilomycin and Chl-chloroquine. C) pHrodo-labeled S. aureus (red) was visualized inside BMDC after 2 h incubation in the presence of AF-488
phalloidin (green) and TO-PRO-3 (blue). Also shown is gentamicin protection assay data from the same experiment (n = 7). D) and F) WT and knockout
BMDC were incubated with 502A for 2 h before Ifnb levels were assessed using qRT-PCR. E) Induction of Ifnb was assessed in WT BMDC in the
presence of the RIP2 inhibitor, gefitinib (Gef) or the EGFR inhibitor AG1478. G) WT and Nod2-/- BMDC were incubated for 2 h with 502A before RNA
was isolated and gene levels quantitated by qRT-PCR. H) WT and knockout BMDC were incubated with 502A for 24 h before IFN- b levels in the cell
supernatant were quantified by ELISA. Data are representative from at least two independent experiments. N = 3. ***P,0.001, **P,0.01 and *P,0.05,
compared to WT BMDC infected controls.
doi:10.1371/journal.ppat.1003951.g005
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virulence remain unsolved. The participation of innate immune
signaling in the prevention and clearance of staphylococcal infection
is established however, the contribution of host signaling to the
pathology elicited by invasive S. aureus has not. In S. aureus
pathogenesis much of the focus is on virulence factors and while
USA300 had an invasive advantage over 502A, 502A had greater
pathogenic propensity in our model of acute murine pneumonia.
This comparison of two well characterized strains of S. aureus
associated with human colonization and infection confirms, as often
observed in human staphylococcal pneumonia, that the intensity of
the inflammatory response induced in the lung correlates with tissue
damage and poor outcome. Moreover, we suggest that staphylo-
coccal induction of the type I IFN cascade is responsible for this
increased pathogenicity. Once across the mucosal barrier equiva-
lent inocula of 502A caused significantly more disease than the
comparator strain USA300 by all of the conventional standards. It
caused greater mortality, was less efficiently cleared from airway
and lung tissue, induced greater destruction of the lung and invoked
a significantly greater proinflammatory response as defined by
cytokine levels and the influx of immune cells. We have
demonstrated that signaling through NOD2 and IRF5 by strain
502A in contrast to TLR9 and IRF1 by USA300 [10] generates an
exuberant type I IFN response and that this type I IFN response is
the predominant factor associated with the induction of pathology
and mortality in a murine model of infection.
The potential of 502A for virulence was well appreciated in the
past, as it was a standard strain used in numerous assays of
phagocytosis and models of infection [34–36]. Yet, except for a
very few notable exceptions, it was quite innocuous when used to
colonize thousands of newborn infants in the 1950’s [14–17].
Our studies identified that the ability of USA300 to invade, and
cross keratinocyte and epithelial cells makes it a virulent organism,
Figure 6. 502A has enhanced autolysis. A) Growth curve of USA300 and 502A. Data is an average of three independent experiments. B) Autolysis
assay of USA300 and 502A. Black line-USA300, grey line-502A. Data is an average of three independent experiments. C) Coomassie stained
polyacrylamide gel of concentrated secreted proteins from USA300 and 502A. Proteins identified by mass spectrometry are indicated. D) Inhibition of
growth of S. aureus by lysostaphin. Shown is a representative of three independent experiments. E) Purified DNA and RNA from USA300 and 502A
was transfected into BMDC and 6 h later Ifnb induction was assessed by qRT-PCR. F) Bacterial lysates were generated by sonication and incubated in
the presence or absence of transfection reagent for 6 h with BMDC. Ifnb levels were then assessed using qRT-PCR. G) Lysates of 502A were generated
using sonication. Lysates were then left untreated (UN) or treated with DNase, RNase or protease before stimulating BMDC and then assessing levels
of Ifnb by qRT-PCR. H) Peptidoglycan was isolated from strains and kept as insoluble or digested to produce soluble peptidoglycan. Samples were
incubated in the presence or absence of transfection reagent for 6 h on BMDC before Ifnb was assessed by qRT-PCR. I) Peptidogylcan quantification
from clarified exponential phase cultures and HaCat supernatant after bacterial exposure. Data are representative of two independent experiments
(n = 3). **P,0.01 and *P,0.05, compared to USA300.
doi:10.1371/journal.ppat.1003951.g006
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particularly since 502A appears to encode a similar genetic
repertoire of virulence factors. One prominent virulence factor
missing from 502A was the Panton-Valentine toxin or PVL
however, we have shown previously that it is not involved in
keratinocyte or epithelial invasion [37,38]. Another factor
enhancing the virulence of USA300 is its ability to survive the
antimicrobial activity of the mucosal barrier. 502A was signif-
icantly more susceptible to products produced by both skin and
airway cells, therefore the increased invasiveness of USA300 may
be a result of its resistance to host antimicrobial killing. In the
acute phase 502A induced greater signaling and release of LDH
by cells, but over time its increased capacity to undergo autolysis
and susceptibility to host products led to reduced persistence in
vitro. Nonetheless, 502A displayed increased virulence in our
murine model of pneumonia that was dependent on its activation
of the type I interferon cascade. We have observed with S. aureus
USA300 that type I IFN signaling is involved in bacterial
clearance and observed a slight reduction in TNF production
[10]. The ability of 502A to induce significantly higher levels of
type I IFN allows us to observe with better clarity the role this
pathway plays in staphylococcal infection. Thus, despite a
relatively impaired ability to invade either locally or systemically,
502A was able to induce a robust inflammatory response that
caused greater damage than that attributed to USA300.
Genomic analysis of 502A as compared with USA300 suggests an
explanation for these observations. The presence of the ACME
element and the spermine/spermidine acetyltransferase SpeG in
USA300, but not 502A, and its association with the ability to
withstand the antimicrobial activity of spermidine and spermine on
human skin could well account for the relative success of USA300 to
avoid epithelial and keratinocyte killing [23,39]. We did observe a
decrease in protein A production in 502A however, we have shown
this factor to not play a role in type I IFN signaling in immune cells
and would expect an increase in expression if we were to attribute
this factor to the enhanced virulence of 502A. While our genomic
analysis did not discover many differences there were several
different secreted protein bands observed between USA300 and
502A that may account for their phenotypic differences. The
conservation of other major classes of virulence factors, the phenol
soluble modulins, a-toxin, as well as other toxins, with the exception
of PVL, suggests that these well accepted virulence factors were not
responsible for the enhanced tissue destruction associated with 502A
pneumonia and further illustrates the role the host response plays in
pathogenesis. Given the increased susceptibility of 502A to mucosal
clearance, its enhanced virulence when delivered intranasally in the
murine model is even more striking.
Phenotypic comparison of 502A and USA300 suggests the
increased propensity of 502A to undergo autolysis is a reason for
Figure 7. Type I IFN signaling contributes to in vivo virulence of 502A. A) WT C57Bl/6J and Ifnar-/- mice were infected with 108 cfu of 502A
for 20 h and mortality assessed (n =WT-13, Ifnar-/--14). WT C57Bl/6J and Ifnar-/- mice were infected with 107 cfu of 502A for 20 h. B) BALF and lung
homogenate were assessed for bacterial numbers. C) Total protein content in BALF (n =WT-19, Ifnar-/--20). D) Cells in BALF were stained with
fluorescent antibodies and analyzed by flow cytometry. E) Cytokines were measured by ELISA from BALF. Data is from at least two independent
experiments. Each point represents a mouse. Lines display median values. ***P,0.001, **P,0.01 and *P,0.05, compared to WT infected controls.
doi:10.1371/journal.ppat.1003951.g007
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its heightened pathogenicity. The ability of the released cell wall
fragments, namely peptidoglycan, to activate cytosolic Nod2 and
IRF5 signaling resulted in a significantly increased induction of
Ifnb, a pathway once previously described in response to
Mycobacterium tuberculosis [29]. It is also interesting to compare the
location of the signaling activated by each strain. USA300 signals
via TLR9, which is located in the endosome, while 502A signals
via the cytosol. One avenue of future investigation will be to
determine the processing differences between these strains. A
penicillin susceptible strain, 502A had an increased rate of
exponential growth, increased production of Atl, a major
autolysin, increased spontaneous autolysis, peptidoglycan release
and corresponding increased susceptibility to cell wall active
antimicrobial. These results suggest that autolysis plays an
important role in the release of peptidoglycan leading to enhanced
type I IFN signaling by 502A. Consistent with the involvement of
NOD2, autolysins aid in cell division through degradation of
peptidoglycan, the ligand for NOD2 [40]. Of note, the induction
of NOD2 and IRF5 appears to be specific to 502A, as previous
studies of Ifnb induction by USA300 demonstrated that signaling
involved staphylococcal DNA activation of TLR9 via IRF1 [10],
an endosomal process in contrast to the cytosolic NOD2 pathway
observed with 502A. The involvement of NOD2 signaling in the
intensity of inflammatory responses is not unexpected as
polymorphisms in NOD2 are closely linked to the pathogenesis
of inflammatory bowel disease, another example of a pathological
response to mucosal bacteria [41–43].
We also observed other differences in signaling activated by the
two staphylococcal strains. There was some involvement of IRF3/
7 at the RNA level for induction of Ifnb, which were associated
with significant reductions in protein levels. MyD88 was also
involved in Ifnb signaling, with a significant decrease in Ifnb RNA
causing a significant drop in IFN-b. MyD88 may also influence
post-transcriptional events in protein production. The ability of
two strains of the same pathogen to activate distinct host innate
immune responses further illustrates the degree of adaptation of
the pathogen to the host as well as redundancy in the immune
system to sense the same species through multiple mechanisms.
Our approach using two disparate strains to understand the
pathogenesis of S. aureus pneumonia is in contrast to most other
studies that use isogenic mutants to query the nature of the host
response. Our data suggest that the intensity of innate immune
signaling, and in this case, the type I IFN cascade, correlates
significantly with the outcome of acute infection. The finding that
502A, used in high dose to inoculate neonates, was highly virulent
was entirely unexpected, particularly in comparison to USA300, in
which nasal colonization and subsequent invasive infection are
closely associated [4,5]. Our results suggest that the prevalence of
Figure 8. Type I IFN signaling contributes to pulmonary pathology in response to S. aureus 502A. WT C57Bl/6J and Ifnar-/- mice were
infected with 107 cfu of 502A for 20 h. H&E sections of lung tissue at A) 206 (scale bar equals 350 mm), B) 1006magnification (scale bar equals
100 mm) and C) 4006magnification (scale bar equals 25 mm).
doi:10.1371/journal.ppat.1003951.g008
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USA300 in invasive infection is due, in large part, to its ability to
persist on skin and mucosal surfaces. Once across the mucosal or
epithelial barrier, the immunostimulatory potential of the ‘‘non-
pathogenic’’ 502A enables this organism to evoke damaging host
immune responses.
Staphylococcal virulence, not unexpectedly, is multifactorial and
involves the relative ability of individual S. aureus strains to activate
type I IFN signaling, once they have crossed the mucosal barrier.
The participation of the host innate immune response to specific
pathogens is a key determinant in the outcome of infection.
Materials and Methods
Bacterial strains and cell culture
S. aureus USA300 FPR3757 [2] and 502A [16] were grown in
Luria Bertani broth at 37uC. Heat-killed preparations of S. aureus
were obtained by heating cells at 65uC for 1.5 h. Minimal
inhibitory concentrations using lysostaphin (Sigma-Aldrich) were
conducted in microtitre plates for 16 h.
To identify differential protein expression overnight cultures of
S. aureus were grown, pelleted and culture supernatant concen-
trated 206 using Amicon 10 kDa columns. Samples were run on
SDS-PAGE, bands excised, digested and identified using LC-MS
spectroscopy and Mascot protein identification software (Colum-
bia University Medical Center Protein Core).
The human keratinocyte cell line HaCat, human bronchial
epithelial line16HBE, mouse BMDC and primary human
keratinocyte cells were grown as described before [38,44,45].
RPMI 2650 human nasal epithelial cells were grown in minimal
essential medium with 10% heat inactivated fetal bovine serum
with penicillin and streptomycin. Murine lung epithelial cells
(MLE) LA4 were grown in F-12K Kaighn’s modification media
with serum and antibiotics as above. Transmigration of S. aureus
across polarized 16HBE airway epithelial cells was performed as
before [37,44]. The human monocyte line THP-1 was grown in
RPMI 1640 (life) with 10% heat inactivated fetal bovine serum
with penicillin and streptomycin. Cells were differentiated by the
presence of 10 nM phorbol-12-myristate-13-acetate for 24 h.
Stimulations with THP-1 cells were at an MOI of 10. Gentamicin
protection assays were performed using an MOI of 25 for 2 h
before cells were washed and 400 mg/ml of gentamicin was
incubated for 2 h before bacteria were serially diluted. For uptake
assays S. aureus was labeled with fluorescein as before [10] and
added for the times indicated before HaCat cells were washed and
analyzed by flow cytometry. Cytotoxicity [lactate dehydrogenase
(LDH)] was measured using the cytotoxicity detection kit (Roche)
according to the manufacturer’s instructions.
BMDC were stimulated with S. aureus (MOI 100) for 2 h for
RNA experiments and 24 h (MOI 10) for cytokine analysis.
Staphylococcal lysate experiments were performed using 16108
inactivated cfu as before [45]. Experiments with cellular inhibitors
were performed by preincubating the cells for 30 min to 1 h prior
to bacterial stimulation using: cytochalasin D 20 mM (Sigma),
dynasore 80 mM [25], chloroquine 10 mM, bafilomycin (Invivo-
gen) 1 mM, gefitinib 10 mM (Invivogen) and AG1478 10 mM
(Calbiochem). Transfection of BMDC was typically performed
using 1 mg of nucleic acid and 5 mg of peptidoglycan using FuGene
(Roche). DNA was extracted using the DNeasy kit (Qiagen) after
lysing S. aureus with 4 U/ml mutanolysin, 10 mg/ml lysostaphin
and 25 mg/ml lysozyme for 1 h at 37uC.
Immunoblotting
Exponential phase cultures (10 ml of OD600 nm 1.0) were
resuspended in EDTA-free protease inhibitor (Roche) with extrac-
tion buffer (30% w/c raffinose, 50 mM Tris-HCl pH 7.5, 20 mM
MgCl2 and 100 mg/ml lysostaphin) and incubated at 37uC for
8 min. Clarified supernatant was mixed with Laemmli sample
bugger with b-mercaptoethanol and boiled for 10 min. Immuno-
blotting was performed with rabbit anti-a-toxin antibody (1:5000)
and anti staphylococcal antibody (1:5000) (704; Santa Cruz
Biotechnology). Densitometry was performed using ImageJ (1.45S).
Genome sequencing and analysis
Genomic DNA was prepared from overnight cultures of 502A
strain (RN6607 BK21236 NRS149) using the Tissue DNeasy kit
(Qiagen) as above. Library preparation and sequencing was done
using the Ion Torrent Personal Genome Machine 316 chip,
performed by the Columbia Genome Center using manufacturer-
specified protocols. Sequence assembly was performed with
Newbler (http://454.com/products/analysis-software/index.asp),
generating 181 total contigs (N50=25, median contig = 2955).
The total size of the contigs was 2,740,204 bp. Preliminary
Annotation was done using the Rapid Annotation using
Subsystem Technology (RAST) server (http://rast.nmpdr.org).
We focused our initial analysis on known S. aureus virulence factors.
To create a heat map representation of selected genes we used
BLAST-blast analysis (http://blast.ncbi.nlm.nih.gov) using default
settings on the megablast algorithm and surveying the nr/nt
databases. Query sequences were from the USA300 TCH1516
genome sequence or the 502A sequence as noted.
Selected S. aureus genomes were used to create a whole genome
phylogenetic matrix of gene coding regions using the Ortholog ID
process [46]. The matrix was further pruned to include only genes
found inmore than 96% of known S. aureus genomes, and includes only
variable nucleotide positions. The final matrix had 93,249 characters.
Phylogenies were constructed using PAUP 4b10 (http://paup.csit.fsu.
edu) using the maximum parsimony criterion with random addition
(RA) followed by tree bisection and reconnection (TBR), Nreps=1000,
with characters and character state transformations given equal weight.
Node support was calculated based on 1000 bootstrap pseudoreplicates
[47] using the heuristic search strategy above.
Peptidoglycan isolation
Isolation of peptidoglycan was performed on 100 ml of
exponential phase culture. Cells were washed in saline before
boiling for 30 min in 4% SDS and left to stand overnight at room
temperature. The next day cells were boiled for a further 15 min,
left to cool for 1 h before centrifugation at 14,0006g for 15 min.
After washing in water the extract was treated with 2 mg/ml
RNase, 2 mg/ml DNase and 10 mg/ml trypsin before washing to
obtain the insoluble fraction. Soluble peptidoglycan was obtained
by treating the sample with 10 mg/ml mutanolysin and 100 mg/ml
lysostaphin overnight at 37uC. Peptidoglycan was quantified from
clarified cultures using the silkworm larvae plasma (SLP) reagent
set (Wako) according to the manufacturer’s instructions.
Autolysis assay
Triton X-100 autolysis assays were performed as described
elsewhere [48].
Mice studies
C57Bl/6J, Tlr2-/-, Mavs-/-, Nod2-/- and Trif-/- and mice were
from Jackson Laboratories, and Tlr7-/- mice were from Regen-
eron. Mice were intranasally infected with 2–56107 cfu of S. aureus
for pneumonia studies, or 76108 cfu for mortality for 20 h as
previously described [10]. Protein content in bronchoalveolar
lavage fluid (BALF) was measured using Bradford protein assay.
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Staining cells for flow cytometry has been described elsewhere
[45]. Cells were labeled with combinations of fluorescein
isothiocyanate-labelled anti-Ly-6G (Gr-1; RB6-8C5; Biolegend),
PerCP-Cy5.5-labelled anti-CD11c (N418; Biolegend), allophyco-
cyanin-labelled anti-MHC II (I-A/I-E; Biolegend) and phycoery-
thrin-labelled anti-NK 1.1 (NKR-P1C, Ly-55; Biolegend). Neutro-
phils were defined as Ly6G+/MHCII2, macrophages as CD11C+/
MHCIIlow-mid and dendritic cells as CD11c+/MHCIIhigh. Data
were analyzed using WinMDI (version 2.8; Joseph Trotter).
RNA analysis
RNA was isolated using the eZNA Total RNA kit (Omega bio-
tek) followed by DNase treatment using DNAfree (Life Technol-
ogies). cDNA was synthesized using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). qRT-PCR was
performed using Power SYBR Green PCR Master Mix (Applied
Biosystems) in a StepOne Plus thermal cycler (Applied Biosystems).
Samples were normalized to b-actin. Primers for mouse actin, Ifnb,
Cxcl1, Cxcl10 and Il6 have been described elsewhere [10,45].
Cytokines
Cytokine levels were quantified using ELISA to IFN-b (PBL
Interferon), CXCL1/KC (R&D Systems), IL-6 (R&D Systems),
IL-1b (eBioscience) and TNF (eBioscience).
Microscopy
Mouse lungs were fixed overnight in 4% paraformaldehyde
before being embedded in paraffin. Slides of paraffin sections were
stained with hematoxylin and eosin (H&E) and imaged on an
Olympus Cx41 microscope and images captured using a Canon
Powershot S5IS camera.
BMDC were incubated with exponential phase bacteria labeled
with 1 mM of pHrodo (Life Technologies) for 2 h. Fluorescein
isothiocyanate phalloidin (Life Technologies) and TO-PRO3 (Life
Technologies) were incubated in the presence of 0.2% Triton X-
100 prior to fixing in 4% paraformaldehyde and visualization with
a Zeiss LSM 510 META scanning confocal microscope
Statistics
Significance of data that followed a normal distribution was
determined using a two-tailed Student t test, and for data that did
not follow a normal distribution, a nonparametric Mann-Whitney
test was used. Dichotomous survival was assessed using the Fisher’s
exact test. Statistical outliers were identified using Grubbs’ test and
removed. Statistics were performed with Prism software (Graph-
Pad, La Jolla LA USA).
Ethics statement
Animal work in this study was carried out in strict accordance
with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health, the
Animal Welfare Act and US federal law. The protocol was
approved by the Institutional Animal Care and Use Committee
(IACUC) of Columbia University (protocol AAAC3059).
Supporting Information
Figure S1 Comparison of protein A and a-toxin produc-
tion. Clarified cell lysates were probed with anti-staphylococcal
antibody to detect protein A and supernatants from overnight
cultures were blotted for a-toxin. Densitometry compared to
USA300 is provided underneath blots. Protein stained (Ponceau S)
membranes are shown for loading controls.
(TIF)
Figure S2 Comparison of USA300 and 502A in growth
and cytotoxicity of cells. Exponential phase USA300 and
502A were incubated with A) HaCat, B) THP-1, C) LA-4 and D)
BMDC cells for 2 h before bacteria were quantified and clarified
supernatants tested for LDH activity. ***P,0.001, **P,0.01 and
*P,0.05, compared to WT levels.
(TIF)
Figure S3 Comparison of secreted proteins between
USA300 and 502A. Strains were grown to either A) exponential
or B) stationary phase, cultures clarified, filter sterilized and then
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